Gotham Asset Management’s Genomic Health, Inc. GHDX Stock Holding History

Gotham Asset Management’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-38,687	Closed	-$2.62M	–	1276
2019 Q3	$2.62M	Buy	38,687 +26,238	+211%	+$1.8M	0.05%	408
2019 Q2	$724K	Sell	12,449 -23,061	-65%	-$1.37M	0.01%	707
2019 Q1	$2.49M	Buy	35,510 +12,003	+51%	+$890K	0.04%	468
2018 Q4	$1.51M	Buy	23,507 +20,022	+575%	+$1.4M	0.02%	558
2018 Q3	$245K	Buy	+3,485	New	+$204K	﹤0.01%	871

Gotham Asset Management's GHDX Position: Q4 2019 in Review

Gotham Asset Management sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 38,687 shares — an estimated $2.62M sold.

Gotham Asset Management first reported a position in GHDX in Q3 2018 and held it in 5 quarters. The position peaked at $2.62M in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Gotham Asset Management reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Gotham Asset Management sold 38,687 Genomic Health, Inc. shares in Q4 2019, an estimated $2.62M.
Gotham Asset Management first reported a position in Genomic Health, Inc. in Q3 2018 and held it in 5 quarters.
Gotham Asset Management's Genomic Health, Inc. position peaked at $2.62M in Q3 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Gotham Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.